Satellos Bioscience (TSX:MSCL) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Days Payable?

Satellos Bioscience's average Accounts Payable for the three months ended in Mar. 2024 was C$1.39 Mil. Satellos Bioscience's Cost of Goods Sold for the three months ended in Mar. 2024 was C$0.00 Mil.

The historical rank and industry rank for Satellos Bioscience's Days Payable or its related term are showing as below:

During the past 4 years, Satellos Bioscience's highest Days Payable was 1911.69. The lowest was 973.33. And the median was 1442.51.

TSX:MSCL's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 150.695
* Ranked among companies with meaningful Days Payable only.

Satellos Bioscience's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

Satellos Bioscience Days Payable Historical Data

The historical data trend for Satellos Bioscience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Days Payable Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

973.33

1,911.69

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Satellos Bioscience's Days Payable

For the Biotechnology subindustry, Satellos Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Days Payable distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Days Payable falls into.

Satellos Bioscience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Satellos Bioscience's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.466	+	1.04)	/	2 )	/	0	*	365
=	1.253					/	0	*	365
=	N/A

Satellos Bioscience's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.04	+	1.748)	/	2 )	/	0	*	365 / 4
=	1.394					/	0	*	365 / 4
=	N/A

Satellos Bioscience Days Payable Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines